Preview: Elevance Health's Earnings
Portfolio Pulse from Benzinga Insights
Elevance Health (NYSE:ELV) is expected to release its quarterly earnings report on January 24, 2024, with an estimated EPS of $5.64. Investors are looking for an earnings beat and positive guidance for future growth. Historically, Elevance Health's stock price has shown mixed reactions to past earnings performances. Currently, shares are down 4.86% over the last 52 weeks, indicating a bearish sentiment among long-term shareholders.
January 23, 2024 | 7:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Elevance Health is anticipated to report quarterly earnings with an estimated EPS of $5.64. Investors will focus on earnings results and future guidance, which could influence the stock's short-term performance.
The short-term impact on ELV's stock price will likely depend on whether the company beats the earnings estimate and provides positive guidance. Historical data shows mixed stock price reactions to past earnings results. The current bearish sentiment among long-term shareholders may temper any positive reaction to an earnings beat unless accompanied by strong future guidance.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100